CARD9 and inflammatory bowel disease: One intriguing CARD9 splice variant, identified as protective in inflammatory bowel disease, eliminates a TRIM62 binding site, preventing CARD9 signaling and bolstering the idea that TRIM62 ubiquitination of CARD9 is critical for its activation12,22.